AgomAb Therapeutics reported total assets of $332.29M and total liabilities of $29.18M for the quarter ended Jun 2026. This balance sheet covers 4 quarters of results from Dec 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance SheetBalance Sheet | Dec2023 | Dec2024 | Dec2025 | Jun2026 |
|---|---|---|---|---|
| Assets | ||||
| Current Assets | ||||
| Cash & EquivalentsCash & Equiv. | 135.48M | 178.42M | 101.52M | 253.10M |
| Short-term InvestmentsInvestments (Current) | 0.01M | 0.01M | 0.01M | |
| Cash & Current Investments | 135.48M | 178.44M | 101.53M | 253.11M |
| Receivables - NetNet Receivables | 2.09M | 4.71M | ||
| Receivables - OtherOther Receivables | 1.17M | 2.49M | ||
| Receivables | 3.26M | 7.20M | ||
| Prepaid Assets | 2.48M | 5.55M | 7.43M | |
| Current Assets | 180.91M | 142.42M | 295.24M | |
| Non-Current Assets | ||||
| Property, Plant & Equipment (Net)PP&E (Net) | 0.64M | 0.59M | 0.51M | |
| Goodwill | 9.53M | 8.96M | 10.12M | 9.84M |
| Intangibles | 22.26M | 20.93M | 23.62M | 22.97M |
| Goodwill & Intangibles | 31.79M | 29.89M | 33.74M | 32.81M |
| Long-Term Deferred Tax | 0.83M | 1.82M | 1.44M | |
| Other Non-Current Assets | 1.86M | 2.53M | 2.63M | |
| Non-Current Assets | 33.83M | 38.14M | 37.06M | |
| Assets | 214.74M | 180.56M | 332.29M | |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts Payables | 8.38M | 12.06M | 13.53M | |
| Payables | 8.38M | 12.06M | 13.53M | |
| Current Leases | 0.28M | 0.29M | 0.26M | |
| Current Taxes | 0.87M | 1.58M | 2.25M | |
| Total Current Liabilities | 9.50M | 21.84M | 22.93M | |
| Non-Current Liabilities | ||||
| Non-Current Deffered Revenue | 1.29M | |||
| Operating Leases | 1.32M | 1.18M | 1.04M | |
| Other Non-Current Liabilities | 8.20M | 3.77M | 3.93M | |
| Total Non-Current Liabilities | 9.52M | 4.95M | 6.25M | |
| Total Liabilities | 8.30M | 19.02M | 26.79M | 29.18M |
| Shareholder's Equity | ||||
| Common Equity | 167.61M | 195.72M | 153.77M | 303.11M |
| Liabilities and Shareholders Equity | 214.74M | 180.56M | 332.29M | |
| Retained Earnings | -124.02M | -213.46M | -242.85M |
Pull AgomAb Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=AGMB&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "AGMB", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=AGMB&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();